Why MetLife’s latest earnings are drawing fresh attention
MetLife (MET) is back in focus after third quarter 2026 results, with revenue of US$20,522 million and net income of US$2,397 million compared with the same period last year.
MetLife’s share price has gained 26.83% year to date, with a 4.31% 90 day share price return pointing to steady positive momentum. A 31.67% 1 year total shareholder return and strong three and five year total shareholder returns suggest longer term holders have already seen meaningful value created.
Spot similar insurance and financial services stocks that may be riding a comparable earnings and balance sheet story by scanning our handpicked list of solid balance sheet and fundamentals (23 results).MetLife’s sharp share price climb and stronger recent earnings pull in two explanations. Is this mainly a reset of sentiment, or does the current valuation line up with what the business is actually delivering?
Most Popular Narrative: 8% Undervalued
MetLife’s last close of $101.87 sits below the analyst consensus Narrative fair value of $110.31. This frames the recent rally as still leaving some headroom according to the analyst consensus Narrative on Simply Wall St that compiles price targets and forecast assumptions.
Continued execution of the New Frontier program, which has already been associated with 10% EPS growth in 2025, a 17% adjusted ROE in the first half of 2026 and direct expense ratios at or better than target, suggests further scope to sustain earnings and free cash flow that underpin MetLife’s current valuation.
See why 29 investors see MetLife as 8% undervalued.
Result: Fair Value of $110.31 (UNDERVALUED)
Still, the MetLife story can wobble if investment spreads stay weak or fee based earnings at MetLife Investment Management remain toward the low end of guidance.
Find out about the key risks to this MetLife narrative.
Next Steps
Seeing both enthusiasm and caution around MetLife in this article, it makes sense to check the data yourself and form a clear opinion. A balanced way to pressure test your view is to weigh the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond MetLife?
Do not stop your research with MetLife. Fresh opportunities often appear where capital is still early, pricing is reasonable, and balance sheets look ready for stress.
- Target early stage potential by scanning the 11 elite penny stocks with strong financials that pair smaller market caps with stronger numbers than you might expect.
- Focus on price versus fundamentals by reviewing the 32 high quality undervalued stocks that combine quality metrics with more modest market expectations.
- Prioritise resilience and stability by filtering for the 29 resilient stocks with low risk scores that seek to limit surprises when conditions get tougher.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com